BioMark and Response to Treatment
BioMark’s Principal Engineer attended the World Congress on Interventional Oncology (WCIO) May 6th – 9th in New York to discuss BioMark’s Response to Treatment program and how it would fit into the rapidly developing interventional oncology market place. BioMark’s Principal Engineer spent the month of March in Japan, Taiwan and China to explore the opportunity […]
Florida Cancer Specialists Foundation – Havana Night
Florida Cancer Specialists Foundation – Havana Night BioMark’s team recently travelled to Florida for “Havana Night” hosted by Florida Cancer Specialists Foundation. It was an inspirational evening meeting leading oncologists who help cancer patients in need with their living expenses while undergoing treatment. It enables those fighting cancer to concentrate on recovering rather than focus […]
Criterion BioScience provides coverage for BioMark Diagnostics in USA
For full article and market brief, please go to http://criterionbioscience.com/biomark-diagnostics/
UVic research discovers a promising new way to detect lung cancer
Cancer Detectives by Suzanne Ahearne It’s good to have a fast metabolism if you’re talking about maintaining a healthy body weight. But cancer cells are also fast metabolizers. It’s what makes them more active and faster-growing than healthy cells. And it’s what makes them so dangerous. But their speed also makes them vulnerable. Long before […]
Biomark Attends Photonics West (California)
BioMark’s paper Surface Enhanced Raman Spectrometer (p-SERS) was on display at the Innovation Photonic Solutions (IPS) booth at the recent Photonics West conference in San Francisco, California. Pictured with BioMark’s Principal Engineer, Jim Elliott is IPS’s Sales Representative Tina Gong. BioMark was privileged to be part of IPS’s booth as IPS is the world leader […]
BioMark Brings New Life to Cancer Detection Technology
by Deborah Bacal from proactiveinvestors.com BioMark (CSE:BUX) has in its hands a diagnostic test that can detect cancer at an early stage, disrupting the current diagnostic market for the disease as we know it and making it easier for both patients and doctors alike. The metabolomics-based test consists of a single, one-shot application of Amantadine, […]
Equities.com Interview with Rashid Ahmed CEO
Cambridge’s 2015 Vancouver Resource Investment Conference in a Nutshell
By Gaalen Engen, Stockhouse.com The 2015 Vancouver Resource Investment Conference, hosted by Cambridge House International, is a regional event that attracts junior from a variety of resource sectors to network, promote and exchange experience in an exciting environment rife with investors, analysts and media.In past years, this event has been the premier meeting ground for the […]
BioMark CBC Radio Interview
BioMark’s CEO Rashid Ahmed was interviewed by Rick Cluff from CBC Radio’s The Early Edition. The full interview is available online at the CBC Radio One [1:20:00] http://www.cbc.ca/earlyedition/pastepisodes/
Global News: Richmond Company Develops Urine Cancer Test
Mon, Jan 5: A BC company is in the final stages of testing a simple new way of detecting cancer. Elaine Yong reports. Your browser does not support frames. Click here to view the frameless video.. Source: Global News http://globalnews.ca/video/1756747/richmond-company-develops-urine-cancer-test
